$108.32
0[0.00%]
At close: Apr 24
$108.32
0[0.00%]
After Hours: 4:00PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
02/28/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2024 | $18.15 | $19.35 | $19.94 | $4.00B | $4.20B | $4.09B | Get Alert |
01/08/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | — | — | — | $3.81B | $3.81B | $3.83B | Get Alert |
01/08/2024 | JAZZ | Jazz Pharmaceuticals | FY | 2025 | — | — | — | $5.00B | $5.00B | — | Get Alert |
11/08/2023 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | $18.15 | $19.00 | $18.66 | $3.75B | $3.88B | $3.83B | Get Alert |
08/09/2023 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | $18.15 | $19.00 | $17.48 | $3.73B | $3.88B | $3.78B | Get Alert |
05/10/2023 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | $16.90 | $17.85 | $17.44 | $3.67B | $3.88B | $3.78B | Get Alert |
03/01/2023 | JAZZ | Jazz Pharmaceuticals | FY | 2023 | $16.90 | $17.85 | $18.00 | $3.67B | $3.88B | $3.76B | Get Alert |
11/09/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2022 | $17.20 | $17.85 | $17.41 | $3.60B | $3.70B | $3.65B | Get Alert |
08/03/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2022 | $16.70 | $17.70 | $17.09 | $3.50B | $3.70B | $3.60B | Get Alert |
05/04/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2022 | — | — | — | $3.50B | $3.70B | $3.58B | Get Alert |
03/01/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2022 | $16.00 | $17.00 | $17.47 | $3.46B | $3.66B | $3.64B | Get Alert |
01/10/2022 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | — | — | — | $3.02B | $3.10B | $3.07B | Get Alert |
11/09/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $15.10 | $15.80 | $14.52 | $3.02B | $3.10B | $3.09B | Get Alert |
08/03/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $13.40 | $14.70 | $14.45 | $3.02B | $3.18B | $3.11B | Get Alert |
06/17/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $13.40 | $14.70 | $15.05 | $3.02B | $3.18B | $3.11B | Get Alert |
05/04/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $15.65 | $16.86 | $16.39 | $2.55B | $2.70B | $2.65B | Get Alert |
04/20/2021 | JAZZ | Jazz Pharmaceuticals | Q1 | 2021 | — | — | — | $605.00M | $610.00M | $613.95M | Get Alert |
02/23/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2021 | $15.65 | $16.85 | $16.78 | $2.55B | $2.70B | $2.56B | Get Alert |
01/12/2021 | JAZZ | Jazz Pharmaceuticals | FY | 2020 | — | — | — | $2.32B | $2.38B | $2.34B | Get Alert |
The last reported Earnings numbers were from February 28, 2024 for the full year 2024 and was for an earnings per share guidance in the range of $18.15 and $19.35 versus the estimated EPS of $19.94.
Browse guidance and forecast on all stocks.